Web Results

digitalcommons.ilr.cornell.edu/cgi/viewcontent.cgi?article=1198&context=condec

Jaffe et al v. Morgan Stanley. Keywords. Daisy Jaffe, Denise Williams, Margaret Benay Curtis-Bauer, Morgan Stanley, Morgan Stanley & Co. Incorporated, Morgan Stanley DW Inc., C-06-3903, Consent Decree, Disparate Treatment, Assignment,. Compensation, Termination, Terms and Conditions, Training / Advancement, ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3011858

Oct 29, 2010 ... Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Botel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371–88.

www.ncbi.nlm.nih.gov/pmc/articles/PMC2637346

Dec 3, 2008 ... Topoisomerase II poisons target both the α and β forms of human topoisomerase II (Cornarotti et al., 1996; Willmore, 1998). ... lives in the United States every year and that five-year survival rates for patients suffering from this cancer are still less than 5% (Jaffee et al., 2002; Fernandez-Zapico et al., 2005).

pdfs.semanticscholar.org/ed63/f3f0dcf0f071e2dd8afeb5b4d1ee3917e332.pdf

to FA (Li et al., 1999). In addition, it connects ILK to other proteins, including Nck- 2, a Src homology 3 (SH3)- and a. SH2-containing adaptor protein, involved in the growth factor receptor kinase signaling pathways (Lehmann et al., 1990; Li et al., 1992; Meisenhelder ... AS) blocked the survival effect of VEGF in annexin-V.

pdfs.semanticscholar.org/74b2/9cd5e8d155bf1740c75d586fc00eb6506f76.pdf

phylogenetic lineages that appear to be host specific; and (v) duplication and deletion ... v. TABLE OF CONTENTS. Page. CHAPTER 1 ANTIMICROBIAL RESISTANCE IN SALMONELLA: A. REVIEW. 1. CHAPTER 2 CEFTIOFUR RESISTANT .... comprehensive review of aminoglycosides is provided by Shaw et al. (90).

pubmedcentralcanada.ca/pmcc/articles/PMC4624487

Oct 14, 2015 ... The precipitant solution consisted of 100 mM BisTris (pH 6.5), 10% (w/v) PEG 35000 (Fluka), and 4 mM TCEP. Crystals of double mutants complexed with the tetrapeptide assay substrate Ac-Arg-His-Lys(Ac)-Lys(Ac)-aminomethylcoumarin ( Enzo Life Sciences) were cocrystallized in similar fashion. Briefly ...

cyberleninka.ru/article/n/exoskeleton-as-a-new-means-in-habilitation-and-rehabilitation-of-invalids-review.pdf

A.A. Vorobyev, MD, DSc, Professor, Head of the Department of Operative Surgery and Topographic Anatomy1,. Head of the Department of Experimental and Clinical Surgery2;. A.V. Petrukhin, PhD, Assistant Professor, Department of Computer-Aided Design and Search Engineering3;. O.A. Zasypkina, PhD, Senior Tutor, ...

bioweb.cbm.uam.es/articles/hummutat36_2015.pdf

Jan 30, 2015 ... postnatal growth failure, intellectual disability, limb malformations, hypertrichosis, and variable involvement of other organ systems. [Kline et al., 2007]. ... et al., 2007; Pie et al., 2010; Wierzba et al., 2012]. A proportion of the .... field implemented in DeepView (http://spdbv.vital-it.ch/), using. 500 steps of ...

onlinelibrary.wiley.com/doi/10.1002/mpo.2950030310/full

Abstract. Fifty-six untreated patients with childhood with acute lymphoblastic leukemia (ALL) were randomized to receive one of three remission induction regimens: vincristine and prednisone (VP), vincristine, prednisone and daunorubicin (VPD), or vincristine, prednisone and adriamycin (VPA). The complete remission rate ...